KRYS Krystal Biotech RESULTS: Q2, Q2 product REV $119.222M, Q2 operating expenses $60.805M, Q2 Operating Income $58.417M, Q2 Net Income $54.
KRYS Krystal Biotech RESULTS: Q2, Q2 product REV $119.222M, Q2 operating expenses $60.805M, Q2 Operating Income $58.417M, Q2 Net Income $54.768M
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.